UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000017546
Receipt number R000020328
Scientific Title Abdominal and pelvic CEST imaging: quantitative assessment of tissue function, tumor characteristic, tumor aggressiveness
Date of disclosure of the study information 2015/05/13
Last modified on 2016/11/12 11:01:29

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Abdominal and pelvic CEST imaging: quantitative assessment of tissue function, tumor characteristic, tumor aggressiveness

Acronym

Abdominal and pelvic CEST imaging: quantitative assessment of tissue function, tumor characteristic, tumor aggressiveness

Scientific Title

Abdominal and pelvic CEST imaging: quantitative assessment of tissue function, tumor characteristic, tumor aggressiveness

Scientific Title:Acronym

Abdominal and pelvic CEST imaging: quantitative assessment of tissue function, tumor characteristic, tumor aggressiveness

Region

Japan


Condition

Condition

Normal tissues and malignant tumors of liver, pancreas, kidney, uterus, prostate and GI

Classification by specialty

Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate function of abdominal tissues, aggressiveness and histological characteristics of malignant tumors using CEST imaging

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Comparison of CEST effects between tumor and non-tumor region.
Assessment of diagnostic capability of tumor aggressiveness and histological characteristics by radiological-histological correlation.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Other

Interventions/Control_1

With or without CEST imaging

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

MRI was performed for the evaluation abdominal or pelvic tumor.
Informed consent was obtained.
Equal or more than 20 years old

Key exclusion criteria

Contraindication of MRI

Target sample size

500


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hiroshi Honda

Organization

Kyushu University

Division name

Department of Clinical Radiology

Zip code


Address

3-1-1 Maidashi, Higashi-ku, Fukuoka City

TEL

092-642-5695

Email

honda@radiol.med.kyushu-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yukihisa Takayama

Organization

Kyushu University

Division name

Department of Clinical Radiology

Zip code


Address

3-1-1 Maidashi, Higashi-ku, Fukuoka City

TEL

092-642-5695

Homepage URL


Email

ytaka@radiol.med.kyushu-u.ac.jp


Sponsor or person

Institute

Kyushu University

Institute

Department

Personal name



Funding Source

Organization

JSPS KAKENHI

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 05 Month 13 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results

There was a significant difference in APTSIs between GS of 6 and GS of 7, and GS of 7 and GS of 9, but no significant differences in APTSI between GS of 6 and GS of 8, GS of 6 and GS of 9, and GS of 7 and GS of 8. The increase The APTSI in GS of 7 was the highest. The APT-MRI has a possibility as a new biomarker of Pca aggressiveness.

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 10 Month 04 Day

Date of IRB


Anticipated trial start date

2012 Year 10 Month 04 Day

Last follow-up date


Date of closure to data entry

2016 Year 04 Month 01 Day

Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 05 Month 13 Day

Last modified on

2016 Year 11 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020328


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name